Salivary biomarker testing represents a minimally invasive approach to detecting molecular signatures of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Unlike cerebrospinal fluid (CSF) collection which requires lumbar puncture, saliva can be collected safely and repeatedly, enabling longitudinal monitoring and large-scale screening programs.
Salivary biomarker testing represents a minimally invasive approach to detecting molecular signatures of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Unlike cerebrospinal fluid (CSF) collection which requires lumbar puncture, saliva can be collected safely and repeatedly, enabling longitudinal monitoring and large-scale screening programs.
Rationale for Salivary Biomarkers
Mermaid diagram (expand to render)
CBS and PSP are 4R-tauopathies characterized by intracellular accumulation of hyperphosphorylated tau protein in neurons and glia. The neurodegenerative process releases various biomarkers into peripheral fluids, including:
Neurofilament light chain (NfL): Marker of neuroaxonal damage
Phosphorylated tau (p-tau181, p-tau217): Specific to tau pathology
Alpha-synuclein: Relevant for differential diagnosis from Parkinson's disease
Cortisol: Indicator of hypothalamic-pituitary-adrenal axis dysregulation
Total protein and inflammatory markers: Reflect neuroinflammation
Salivary glands are innervated by autonomic fibers and may reflect CNS pathology through:
Centrifuge at 2,000 × g for 10 minutes within 30 minutes
Store supernatant at -80°C
Avoid repeated freeze-thaw cycles
Note collection time for cortisol normalization
Biomarker Panel for CBS/PSP
Neurofilament Light Chain (NfL)
NfL is released during axonal damage and is elevated in various neurodegenerative conditions. Salivary NfL shows moderate correlation with CSF NfL, though concentrations are approximately 100-fold lower.
Key findings:
Elevated in CBS compared to healthy controls
Higher levels in PSP than CBS in some cohorts
Correlates with disease severity and progression rate
Potential for distinguishing CBS from AD
Phosphorylated Tau (p-tau181, p-tau217)
Phosphorylated tau species are disease-specific biomarkers. Salivary p-tau detection remains technically challenging due to low concentrations.
Current evidence:
p-tau181 detectable in saliva using ultrasensitive immunoassays (SIMOA)
Higher in CBS/PSP than controls
p-tau217 shows higher diagnostic accuracy than p-tau181
More studies needed for validation
Alpha-Synuclein
Alpha-synuclein pathology can be assessed through seed amplification assays applied to salivary samples.
The following diagram shows the key molecular relationships involving Salivary Biomarkers in Corticobasal Syndrome discovered through SciDEX knowledge graph analysis: